Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.
Back to team page
Mihir Bhatt
Director
Mihir has over 15 years of marketing research experience, working with a diverse set of categories including consumer packaged goods, technology, finance, automotive, and more – helping businesses turn research into true, impactful insights. Mihir has a BS in Health Sciences and an MBA in Marketing & Finance from Purdue University.
Bold facts
Learn more about

Your favorite part of working at Bold Insight:

In your spare time you would absolutely do this:

What fictional family would you like to join?

Your favorite city in the world is...and why?

Favorite book:

Best piece of advice you’ve been given:

What superpower would you most want?

Any other facts to share?
Read our team’s latest bold insights
Designing your POS so it’s not a POS
Regardless of whether the interface is intended to be used by a customer (novice) or an employee (expert), the key is to ensure that the POS interface is designed for the intended audience. To do this, organizations should engage users throughout the design process.
FDA’s digital health precertification program emphasizes importance of post-market surveillance
Finding efficient ways to leverage post-market surveillance data to inform product development at an institutional level will be key for SaMD manufacturers seeking FDA precertification.
5 takeaways for human factors practitioners from the HFES Health Care Symposium FDA workshops
Healthcare symposium provides clarity for interpretation of FDA guidance documents related to human factors engineering.